Novel Egr/NF-AT composite sites mediate activation of the CD95 (APO-1/Fas) ligand promoter in response to T cell stimulation
Min Li‐Weber(German Cancer Research Center), Peter H. Krammer(Slovak Academy of Sciences), Oskar Laur(German Cancer Research Center)
European Journal of Immunology
September 1, 1999
Cited by 70
Related Papers
FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex
|Cell|1996|3.1k
Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor.
|The EMBO Journal|1995|2.2k
Death and anti-death: tumour resistance to apoptosis
|Nature reviews. Cancer|2002|2.1k
Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
|Science|1989|1.7k
Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
|Nature|1995|1.6k